Postmenopausal vaginal atrophy (PVA) is the reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy. Symptoms of vaginal atrophy include redness, burning, itching, dyspareunia, and irritation. For correcting PVA various drug therapies are available such as estrogen based therapy and non-estrogen based therapy.
MARKET DYNAMICS
The key market drivers for Postmenopausal Vaginal Atrophy Drugs Market Includes, rise in prevalence of postmenopausal vaginal atrophy cases along with advancement in medical care facilities. Additionally, availability of various drug therapies in ranges of dosage form is also expected to drive market growth during the forecast period. However, less diagnosis rate and less awareness about PVA is expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Postmenopausal Vaginal Atrophy Drugs Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Postmenopausal Vaginal Atrophy Drugs market with detailed market segmentation by therapy type and drug forms. The Postmenopausal Vaginal Atrophy Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Postmenopausal Vaginal Atrophy Drugs Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Postmenopausal Vaginal Atrophy Drugs Market is segmented on the basis of therapy type and drug forms. On the basis of therapy type the market is segmented as, estrogen based drugs, non-estrogen based drugs. On the basis of drug forms the market is segmented as, vaginal gels, creams, tablets and patches.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Postmenopausal Vaginal Atrophy Drugs Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Postmenopausal Vaginal Atrophy Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Postmenopausal Vaginal Atrophy Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Postmenopausal Vaginal Atrophy Drugs Market in these regions.
MARKET PLAYERS
The report covers key developments in the Postmenopausal Vaginal Atrophy Drugs Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Postmenopausal Vaginal Atrophy Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Postmenopausal Vaginal Atrophy Drugs market in the global market. Below mentioned is the list of few companies engaged in the Postmenopausal Vaginal Atrophy Drugs Market.
The report also includes the profiles of key players in Postmenopausal Vaginal Atrophy Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Actavis plc
- Bionovo, Inc
- Endoceutics, Inc
- Novo Nordisk A/S
- Pfizer Inc
- Teva Pharmaceuticals Ltd
- Therapeutics MD, Inc
- Shionogi and company Limited
- Allergan Plc
- Pfizer Inc
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.